September 8, 2016 in Blog
Based on last year It was one of the top 10% rated courses
AAO ITEDS course 244 – ROOM S106A – Sunday, October 16, 2016 – 2:00-4:00pm
AAO Website description
Synopsis Thyroid eye disease (TED) can be challenging to manage. This course will provide a practical update to help the ophthalmologist care for the patient with TED. The ITEDS “VISA” standardized evaluation form will be utilized in the discussion of the clinical evaluation and management of this disorder. An overview of favored approaches for surgical management will also be provided. Objectives By the conclusion of this course, participants should understand (1) disease activity, progress, and severity, (2) the ITEDS-VISA classification, (3) the use of the ITEDS-VISA classification for management, (4) management during the active phase, including conservative therapy, medical therapy, radiotherapy, and urgent surgery, and (5) management during the quiescent phase, including conservative therapy and surgical intervention.
Download outline of the program – click here
ITEDS AGM will be held from 4.30pm to 6pm on the 7th floor at the Palmer House Hotel (2 miles from the McCormick Center and on the shuttle schedule for AAO).
All are welcome to attend
December 27, 2015 in Blog
4th ITEDS International Thyroid Eye Disease – Course and Symposium
Queen Elizabeth II Centre, Westminster, London, UK
Course: Thursday, June 23, 2016
Symposium: Friday and Saturday, June 24 and 25, 2016
ITEDS held a very successful course and symposium in June 2016 in London attended by over 300 delegates. Many clinical leaders from all over the World gave insight into the diagnosis, investigation and treatment of TED. The latest research from laboratory based to clinical investigations were presented and discussed.
Jimmy Uddin ITEDS President
December 24, 2015 in Blog
ITEDS hosted its seventh annual teaching course for comprehensive ophthalmologists and oculoplastics subspecialists at the American Academy of Ophthalmology (AAO) in Las Vegas in November, 2015.
The focus was evaluation of thyroid eye disease using ITEDS-VISA forms, concepts of disease activity and severity, and current medical and surgical management. Case presentations were assessed by the audience with interactive dialogue with panelists.
The course was well attended by over 150 comprehensive ophthalmologists and oculoplastic surgeons from throughout the world. The AAO is the largest meeting in the world for eye surgeons.
The next course has been approved for Chicago in November, 2016. Announcements about date and venue will be made closer to the date.